Suchergebnisse - "Gabay, Cem"

PubPharm (18)

1

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept : Results from the international TOCERRA and PANABA observational collaborative studies

enthalten in: Joint bone spine | 2024

von Lauper, K. | Mongin, D. | Bergstra, S. | +20

2

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA) : a double-blind, multicentre, randomised controlled trial

enthalten in: Lancet (London, England) | 2020

von Burmester, G. | Buttgereit, F. | Bernasconi, C. | +57

CommentIn: Lancet. 2020 Jul 25;396(10246):218-219. - PMID 32711782

3

Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes : retrospective analysis of DAS28 responses in comparative tocilizumab studies

enthalten in: Rheumatology international | 2020

von Koehm, M. | McIntosh, M. | Hofmann, M. | +6

4

Response to : 'When binary and continuous responses disagree' by Dr Ouyang

enthalten in: Annals of the rheumatic diseases | 2020

von Lauper, K. | Courvoisier, D. | Gabay, C.

CommentOn: . - PMID 29730637

5

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis

enthalten in: Seminars in arthritis and rheumatism | 2020

von Lauper, K. | Mongin, D. | Iannone, F. | +14

6

Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab

enthalten in: Advances in rheumatology (London, England) | 2019

von Tuckwell, K. | Gabay, C. | Sornasse, T. | +3

7

Drug retention of biological DMARD in rheumatoid arthritis patients : the role of baseline characteristics and disease evolution

enthalten in: Rheumatology (Oxford, England) | 2019

von Lauper, K. | Mongin, D. | Alpizar-Rodriguez, D. | +10

8

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug : analyses from the pan-European TOCERRA register collaboration

enthalten in: Annals of the rheumatic diseases | 2018

von Lauper, K. | Nordström, D. | Pavelka, K. | +13

CommentIn: Ann Rheum Dis. 2020 Apr;79(4):e38. - PMID 30683675

9

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

enthalten in: RMD open | 2018

von Lauper, K. | Mongin, D. | Iannone, F. | +11

ErratumIn: RMD Open. 2019 Dec 23;5(2):e000809corr1. - PMID 31921442

10

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials

enthalten in: RMD open | 2017

von Strand, V. | Michalska, M. | Birchwood, C. | +6